Abstract
Interleukin-1 (IL-1) is involved in a variety of immune system activities, such as acute phase response, fever and cartilage breakdown. The acute phase response is a result of injury, virus or bacterial infection, all of which induce acute phase protein synthesis. Expression of the acute phase proteins is predominantly regulated by IL-1 and IL-6; however, the liver centrally regulates the acute-phase response by inducing the release of acute phase reactants (APRs). There are two classes of these acute phase reactants. IL-1 induces class 1 acute phase proteins, such as serum amyloid A and 1acid glycoprotein, synergistically, with or without IL-6. However, class 2 APRs, including various anti-proteases and 2-macroglobin, are induced only by IL-6. The promoters of some of the acute phase genes contain regulatory respond elements called acute phase response elements (APRE). APRE bind to transcription factors termed acute-phase response factor (AFRF) or to the signal transducer and activator of transcription 3, (Stat3). Additional types of regulatory elements found in promoters of APRs are CCAAT enhancer-binding protein (C/EBP) and nuclear factor-N3 (NF-NB) binding elements that bind to C/EBP family of transcription factors such as NF-IL6, C/EBPI and NF-NB respectively. IL-1 only activates NF-A8 and C/EBP transcription factors; however, IL-6 activates Stat3 molecules.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Dinarello, C.A., 1996, Biological basis for Interleukin 1 in diseases.Blood87, 2095–2147.
Shen, X., Tian, Z., Holtzman, M.J., and Gao, B., 2000, Cross-talk between interleukin lE and IL-6 signaling pathways: IL-1E selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism.Biochem. J.352, 913–919.
Wilson, D.R., Juan, T.S., Wilde, M.D., Fey, G.H., and Darlington, G.J., 1990, A 58-basepair region of the human C3 gene confers synergistic inducibility by interleukin-1 and interleukinMol Cell Biol. 106181–6191.
Hocke, G.M., Barry, D., and Fey, G.H., 1992, Synergistic action of interleukin-6 and glucocorticoids is mediated by the interleukin-6 response element of the rat alpha 2 macroglobulin gene.Mol Cell Biol.12, 2282–94.
Wegenka, U.M., Lutticken, C., Buschmann, J., Yuan, J., Lottspeich., F., Muller-Esterl, W., Schindler, C., Roeb, E., Heinrich, P.C., and Horn, F., 1994, The interleukin-6activated acute phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family.Mol Cell Biol.14, 3186–96.
Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S., Nishio, Y., Nakajima, T., Hirano, T., and Kishimoto, T., 1990, A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J.9, 1897–906.
Rothwarf, D.M., and Karin, M., 1999, The NF-kappa E activation pathway: a paradigm in information transfer from membrane to nucleus.Sci STKE 5Review.
Auron P.E., 1998, The interleukin 1 receptor: ligand interactions and signal transduction.CytokineGrowth Factor Rev. 9, 221–37.
Tsukada, J., Waterman, W.R., Koyama, Y., Webb, A.C., and Auron, P.E., 1996, A novel STAT-like factor mediates lipopolysaccharide, interleukin 1 (IL-1), and IL-6 signaling and recognizes a gamma interferon activation site-like element in the IL1E gene. Mol Cell Biol. 16, 2183–94.
Schumann, R.R., Kirschning, C.J., Unbehaun, A., Aberle, H.P., Knope, H.P., Lamping, N., and Herrmann, F. 1996, The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Mol. Cell Biol. 16, 3490–503.
Morton, N.M., de Groot, R.P., and Emilsson, V., 1999, Interleukin-1E activates a short STAT-3 isoform in clonal insulin-secreting cells. FEBS Lett. 442, 57–60.
Zhang, Z., and Fuller, G.M., 2000, Interleukin lE inhibits interleukin 6-mediated rat $ fibrinogen gene expression.Hemostasis Thrombosis Vasc. Biol.96, 3466–3472.
Benkhart, E.M., Siedlar, M., Wedel, A., Werner, T., Ziegler-Heitbrock, H.W., 2000, Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression.J. Immunol.1651612–7.
Bromberg, J., 2002, Stat proteins and oncogenesis.J Clin Invest.109, 1139–42.
Schindler, C., and Darnell, J.E. Jr.1995, Transcriptional responses to polypeptide ligands: the JAK-STAT pathwayAnnu Rev Biochem.64621–51. Review.
Akira, S., Nishio, Y., Inoue, M., Wang, X.J., Wei, S., Matsusaka, T., Yoshida, K., Sudo, T., Naruto, M., and Kishimoto, T.,1994, Molecular cloning of APRF, a novel IFNstimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 77, 63–71.
Kuno, K., and Matsushima, K., 1994, The IL-1 receptor signaling pathway.J. Leukoc. Biol.56, 542–7. Review.
Yoo, J.Y., Wang, W., Desiderio, S., and Nathans, D., 2001, Synergistic activity of STAT3 and c-Jun at a specific array of DNA elements in the alpha 2-macroglobulin promoter. J. Biol. Chem. 276, 26421–9.
Seidel, H.M., Milocco, L.H., Lamb, P., Darnell, J.E., Jr, Stein, R.B., and Rosen, J.,1995, Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc. Natl. Acad. Sci. USA 92, 3041–3045.
Wagner, B.J., Hayes, T.E., Hoban, C.J., and Cochran, B.H., 1990, The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J. 9, 4477–84.
David, M., 1995, Trancription factors in interferon signaling. Pharm. Ther. 65, 149 161.
Zhong, Z., Wen, Z., and Darnell, J.E. Jr., 1994, Stat3:a stat family member activated by tyrosine phosphorylation in respons to EGF and IL-6. Science 264, 95–98.
Schuringa, J.J., Schepers, H., Vellenga, E., and Kruijer, W., 2001, Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation. FEBS Lett. 495, 71–6.
Finidori, J., and Kelly, P.A., 1995, Cytokine receptor signalling through two novel families of transducer molecules: Janus kinases, and signal transducers and activators of transcription. J. Endocrinol. 147, 11–23.
Wilks, A.F., and Oates, A.C., 1996, The JAK/STAT pathway. Cancer Surv. 27, 139–63.
Boulton, T.G., Zhong, Z., Wen, Z., Darnell, J.E. Jr, Stahl, N., and Yancopoulos, G.D., 1995, STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase. Proc. Natl. Acad. Sci. USA. 92, 6915–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Arman, A., Auron, P.E. (2003). Interleukin 1 (IL-1) Induces the Activation of Stat3. In: Elçin, Y.M. (eds) Tissue Engineering, Stem Cells, and Gene Therapies. Advances in Experimental Medicine and Biology, vol 534. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0063-6_22
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0063-6_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4907-5
Online ISBN: 978-1-4615-0063-6
eBook Packages: Springer Book Archive